天美传媒

Journal of Cellular and Molecular Pharmacology
天美传媒 Access

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 天美传媒 Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

天美传媒 Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Perspective Article   
  • J Cell Mol Pharmacol, Vol 5(5): 104
  • DOI: 10.4172/jcmp.1000104

Neovascular Age-related Macular Degeneration and its Molecular Delivery Strategies alongside with Ocular Therapeutics

Archana Rai*
Department of cellular biology, Ashesi University, Ghana
*Corresponding Author : Archana Rai, Department of cellular biology, Ashesi University, Ghana, Email: archana.r@gmail.com

Received Date: Oct 01, 2021 / Accepted Date: Oct 15, 2021 / Published Date: Oct 22, 2021

Citation: Archana R (2021) Neovascular Age-Related Macular Degeneration and its Molecular Delivery Strategies alongside with Ocular Therapeutics. J Cell Mol Pharmacol 5: 104. Doi: 10.4172/jcmp.1000104

Copyright: © 2021 Archana R. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Select your language of interest to view the total content in your interested language

Post Your Comment Citation
Share This Article
Article Tools
Article Usage
  • Total views: 3107
  • [From(publication date): 0-2021 - Dec 12, 2025]
  • Breakdown by view type
  • HTML page views: 1876
  • PDF downloads: 1231
International Conferences 2025-26
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top Connection closed successfully.